Thu, January 4, 2024
Wed, January 3, 2024
Tue, January 2, 2024
Fri, December 29, 2023
Thu, December 28, 2023
Wed, December 27, 2023
Tue, December 26, 2023
Fri, December 22, 2023
Thu, December 21, 2023
Wed, December 20, 2023
Tue, December 19, 2023

Raghuram Selvaraju Reiterated (ACRS) at Strong Buy and Held Target at $9 on, Dec 29th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-9-on-dec-29th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "Aclaris Therapeutics, Inc." (ACRS) at Strong Buy and Held Target at $9 on, Dec 29th, 2023.

Raghuram has made no other calls on ACRS in the last 4 months.



There are 4 other peers that have a rating on ACRS. Out of the 4 peers that are also analyzing ACRS, 3 agree with Raghuram's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Alex Thompson of "Stifel" Maintained at Hold with Decreased Target to $1 on, Monday, December 18th, 2023
  • Louise Chen of "Cantor Fitzgerald" Downgraded from Buy to Hold on, Tuesday, November 14th, 2023
  • Tim Lugo of "William Blair" Downgraded from Buy to Hold on, Monday, November 13th, 2023


This is the rating of the analyst that currently disagrees with Raghuram


  • Gavin Clark-Gartner of "Evercore ISI Group" Initiated at Buy and Held Target at $22 on, Tuesday, October 3rd, 2023

Publication Contributing Sources